JACCSpertus et al.Clinical Trial

John A. Spertus works in Cross-Cutting Cardiology affiliated with University of Missouri–Kansas City.
John A. Spertus, MD, MPH is a cardiologist, the Lauer/Missouri Endowed Chair and Professor of Medicine at the University of Missouri-Kansas City, and Clinical Director of Outcomes Research at Saint Luke’s Mid America Heart Institute. He developed the Seattle Angina Questionnaire and the Kansas City Cardiomyopathy Questionnaire, which are international standards for measuring symptoms, function, and quality of life in coronary artery disease and heart failure. He received his MD from the University of California, San Francisco and completed internal medicine, cardiology, and health services training at the University of Washington.
1,978 pubs · 119,121 cites · h-index 152
MD
University of California, San Francisco
1989
MPH
University of Washington
1994
BS
Tufts University
Lauer/Missouri Endowed Chair and Professor of Medicine
University of Missouri-Kansas City · 2010 - Present
Director, Healthcare Institute for Innovations in Quality
University of Missouri-Kansas City · 2022 - Present
Clinical Director of Outcomes Research
Saint Luke’s Mid America Heart Institute · 1996 - Present
JACCSpertus et al.Clinical Trial
General / Preventive / Lipids · Methodist Hospital
Really the most important thing to a patient is being alive, their overall survival. I don't think the cause of death is as important as whether or not someone is alive or dead. So the major detail that I go over when I'm with patients is overall survival, then if somebody has a particular preference to undergo revascularization to reduce their risk of cardiovascular death, then I try to respect that preference.
JAMAHochman et al.
American Heart JournalBangalore et al.RCT
Does an initial invasive strategy of cardiac catheterization and optimal revascularization added to optimal medical therapy reduce the composite of all-cause death or nonfatal myocardial infarction compared with a conservative strategy of optimal medical therapy alone in patients with stable ischemic heart disease, moderate or severe ischemia, and advanced chronic kidney disease?
Trial design addresses evidence gap in advanced CKD; extends randomized evaluation of invasive strategy to this high-risk group.
JACCArnold et al.RCT
Does an invasive management strategy compared with a conservative strategy differentially improve 1-year angina-related health status (SAQ Summary Score) across specific baseline patient characteristics in patients with chronic coronary disease and moderate-to-severe ischemia?
Younger patients and those with worse baseline angina gain more health status benefit from invasive strategy; extends ISCHEMIA by identifying treatment effect modifiers for shared decisions.

JACCWalsh et al.Original Research
JACCBrindis et al.Original Research
Cardiac Arrest and Resuscitation · Saint Luke's Health System
I think that's what the message of this paper is: for older adults, we need to be thoughtful before referring them straight to catheterization because some older adults may derive less improvements in their health status and quality of life than younger patients with revascularization as compared with medical therapy.
Journal of the American College of CardiologyNguyen et al.
Circulation Population Health and OutcomesGirard et al.cross-sectional
What are the interrelationships between KCCQ domains, age, and sex in adult outpatients with heart failure and reduced ejection fraction?
KCCQ domains may support integrated assessment without age/sex adjustment in HFrEF; extends interrelationship mapping but leaves open longitudinal validation.
Journal of Cardiac FailurePaquette et al.Guideline
Journal of the American Heart AssociationCantú-Martínez et al.Human Clinical Trial
Circulation Heart FailureGrady et al.cohort
Do heart transplantation and long-term mechanical circulatory support improve health-related quality of life in older patients with advanced heart failure?
Long-term MCS linked to lower HRQoL than HT without prior support in older adults; hypothesis-generating and should not yet change practice.
Interventional / Structural Cardiology · University of Michigan
I'm not sure if turning an interventional cardiologist into a 'human QCA machine' is necessarily the answer. I think the real opportunity is to understand why and when discrepancies may occur that would change clinical decision making and outcomes.
CirculationNallamothu et al.
JACCMessenger et al.Registry Study
How accurately does data abstracted into National Cardiovascular Data Registry programs reflect source medical records?
The National Cardiovascular Data Registry (NCDR) Data Quality Program ensures high data fidelity, with 2010 audits demonstrating raw data abstraction accuracy ranging from 89.7% to 93.1% across major registries.
JACCPatel et al.Guideline
When is coronary revascularization appropriate across varying clinical presentations of coronary artery disease?
Refines revascularization indications in coronary disease; extends prior AUC with expert consensus but leaves open prospective validation.
JACC Heart FailureGirard et al.Original Research
Journal of the American Heart AssociationMurphy et al.cohort
Does health status recovery (measured by EQ-5D-5L VAS, angina, physical function, frailty, fatigue, and depression) over 4 months differ between patients hospitalized with type 2 myocardial infarction compared to type 1 myocardial infarction?
Type 2 MI recovery shows smaller health status gains; hypothesis-generating for targeted interventions addressing frailty and function.
Cardiologist, Beth Israel Deaconess Medical Center · Beth Israel Deaconess Medical Center
We're seeing reversals across several foundational drivers of CV health. Hypertension is a prime example — nearly one in two U.S. adults now meets criteria for high BP, and many are unaware they even have it. Despite being highly treatable, progress in detection, treatment and control has largely stalled over the past decade. Diabetes prevalence and complications continue to rise, particularly among younger adults and people with lower incomes, and obesity has reached epidemic levels across nearly every demographic group.
Journal of the American College of CardiologyMasoudi et al.
JACCIkemura et al.cohort
Does an initial invasive strategy improve angina trajectories over time in patients with chronic coronary disease and baseline angina compared to a conservative strategy?
Patients with chronic coronary disease and angina experience diverse symptom trajectories, with an initial invasive strategy leading to more favorable angina resolution patterns over two years compared to conservative management.
JACCSmolderen et al.cross-sectional
Does health insurance status affect the prescription rates of evidence-based medications in outpatients with coronary artery disease?
Disparities in evidence-based medication prescription for uninsured CAD patients are largely driven by the specific practice sites where they receive care, highlighting the need for site-level quality improvement.
CirculationGrundy et al.Original Research